Opulen Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$205K Buy
223
+14
+7% +$14.2K 0.14% 114
2025
Q4
$225K Buy
+209
New +$200K 0.16% 98

Other funds holding LLY

Opulen Financial Group's LLY Position: Q1 2026 in Review

Opulen Financial Group increased its Eli Lilly (LLY) stake by 6.7% in Q1 2026, buying an estimated $14.2K and bringing the position to 223 shares worth $205K. The position accounts for 0.14% of the portfolio, ranked #114.

Opulen Financial Group first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $225K in Q4 2025. 4,351 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Opulen Financial Group held 223 shares of Eli Lilly worth $205K as of Q1 2026.
  • Opulen Financial Group bought 14 Eli Lilly shares in Q1 2026, an estimated $14.2K.
  • Eli Lilly made up 0.14% of Opulen Financial Group's portfolio in Q1 2026, its #114 holding.
  • Opulen Financial Group first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Opulen Financial Group's Eli Lilly position peaked at $225K in Q4 2025.
  • 4,351 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Opulen Financial Group's 13F filing for Q1 2026, filed 29 Apr 2026.